Bayesian Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,400
| Closed | -$229K | – | 663 |
|
|
2024
Q2 | $229K | Buy |
+9,400
| New | +$229K | 0.03% | 573 |
|
|
2023
Q2 | – | Sell |
-9,499
| Closed | -$228K | – | 782 |
|
|
2023
Q1 | $228K | Buy |
+9,499
| New | +$228K | 0.03% | 580 |
|
|
2022
Q4 | – | Sell |
-11,399
| Closed | -$169K | – | 771 |
|
|
2022
Q3 | $169K | Buy |
+11,399
| New | +$169K | 0.03% | 539 |
|
|
2022
Q2 | – | Sell |
-8,300
| Closed | -$224K | – | 775 |
|
|
2022
Q1 | $224K | Buy |
+8,300
| New | +$224K | 0.03% | 619 |
|